K Number
K163352
Device Name
Wheelchair
Date Cleared
2017-07-28

(240 days)

Product Code
Regulation Number
890.3850
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.
Device Description
The proposed device, Wheelchair model HM303, is traditional manually operated, user propelled, manual, mechanical wheelchairs. The device can be foldable easily for transport. The main frame is made of magnesium alloy frame, which has a seat base with four-wheeled with a back cover. Upon the outside of this framework, and to the rear, are assembled two axle plates, wheels are connected to the stainless steel axle receivers via stainless steel axles. On the front end of the frame are assembled two caster housings. Caster forks are mounted to these housings via steel axles. On the front end of the frame, upon the caster, two footplates are assembled for foot holding. Two armrests are mounted on the frame for user's arm holding. Two grips mounted on the top end of the frame with a brake, and another brake is designed under the seat base. A folden set is on the frame, under the grips, for folding backrest.
More Information

Not Found

No
The device description and performance studies indicate a traditional, manually operated mechanical wheelchair with no mention of AI or ML components.

No
A therapeutic device is one that treats or manages a disease or condition. This device, a wheelchair, provides mobility but does not treat or manage a medical condition.

No
The device description clearly states it is a wheelchair intended for mobility, not for diagnosis. There is no mention of diagnostic capabilities, measurements, or analysis of medical conditions.

No

The device description clearly outlines a physical, mechanical wheelchair made of materials like magnesium alloy and stainless steel, with components like wheels, frame, footplates, and armrests. This is a hardware device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is clearly stated as providing mobility to persons restricted to a sitting position. This is a physical function, not a diagnostic test performed on samples taken from the human body.
  • Device Description: The description details a mechanical wheelchair with components for mobility and user support. There is no mention of reagents, assays, or any components used for analyzing biological samples.
  • Lack of IVD Indicators: The document does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Detecting or measuring substances in the body
    • Diagnosing diseases or conditions based on sample analysis
    • Using laboratory equipment or procedures

The device is a medical device, specifically a mobility aid, but it does not fit the definition of an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Product codes

IOR

Device Description

The proposed device, Wheelchair model HM303, is traditional manually operated, user propelled, manual, mechanical wheelchairs. The device can be foldable easily for transport.

The main frame is made of magnesium alloy frame, which has a seat base with four-wheeled with a back cover. Upon the outside of this framework, and to the rear, are assembled two axle plates, wheels are connected to the stainless steel axle receivers via stainless steel axles. On the front end of the frame are assembled two caster housings. Caster forks are mounted to these housings via steel axles. On the front end of the frame, upon the caster, two footplates are assembled for foot holding. Two armrests are mounted on the frame for user's arm holding. Two grips mounted on the top end of the frame with a brake, and another brake is designed under the seat base. A folden set is on the frame, under the grips, for folding backrest.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:

Safety Testing
ISO 7176-1:2014 Wheelchairs - Part 1: Determination of static stability.
ISO 7176-3:2012 Wheelchairs – Part 3: Determination of effectiveness of brakes.
ISO 7176-5:2008 Wheelchairs - Part 5: Determination of dimensions, mass and manoeuvring space.
ISO 7176-7:1998 Wheelchairs - Part 7: Measurement of seating and wheel dimensions.
ISO 7176-8:2014 Wheelchairs - Part 8: Requirements and test methods for static, impact and fatigue strengths.
ISO 7176-11:2012 Wheelchairs - Part 11 Test Dummies
ISO 7176-13:1989 Wheelchairs - Part 13 Determination of Coefficient of Friction of Test Surfaces.
ISO 7176-15:1996 Wheelchairs – Part 15: Requirements for information disclosure, documentation and labeling.
ISO 7176-16:2012 Wheelchairs – Part 16: Resistance to ignition of postural support device.
ISO 7176-22:2014 Wheelchairs - Part 22 Set-up Procedures

Biocompatibility Performance
Cytotoxicity Test
Test Method: MTT Method, MEM with 10%FBS extract
Test Standard: ISO 10993-5: 2009, Biological evaluation of medical devices - Part 5: Tests for In Vitro cytotoxicity.
Test Result: Did not show potential toxicity

Skin Sensitization Test
Test Method: Guinea Pig Maximization Test, 0.9% Sodium Chloride Injection Extract & Sesame oil Extract
Test Standard: ISO 10993-10: 2010, Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization.
Test Result: No significant evidence of causing skin sensitization.

Skin Irritation Test
Test Method: 0.9% Sodium Chloride Injection Extract & Sesame oil Extract
Test Standard: ISO 10993-10: 2010, Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization.
Test Result: Negligible

No Clinical Test conducted.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K153328

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 890.3850 Mechanical wheelchair.

(a)
Identification. A mechanical wheelchair is a manually operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.(b)
Classification. Class I (general controls).

0

Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular, with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. In the center of the seal is an abstract symbol that resembles a stylized caduceus or a representation of human profiles. The symbol is composed of three interconnected profiles facing to the right, with flowing lines beneath them.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 July 28, 2017

Kunshan Hi-Fortune Health Products Co., Ltd. % Ray Wang General Manager Beijing Believe Technology Service Co., Ltd. 5-1206, Build 332, DaFangJu, No.25 BanBiDian Rd. LiYuan Town, TongZhou District, Beijing, 101121 CN

Re: K163352

Trade/Device Name: Wheelchair Regulation Number: 21 CFR 890.3850 Regulation Name: Mechanical Wheelchair Regulatory Class: Class I Product Code: IOR Dated: June 22, 2017 Received: June 26, 2017

Dear Ray Wang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

1

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

for

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

William J. Heetderks -S 2017.07.28 13:46:07 -04'00'

Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

510(k) Number (if known)

K163552

Device Name Wheelchair

Indications for Use (Describe)

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Type of Use (Select one or both, as applicable)

] Prescription Use (Part 21 CFR 801 Subpart D)

× Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."


EF

PSC Publishing Services (301) 443-6740

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

3

510(k) Summary

This 510(k) Summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of SMDA 1990 and Title 21, CFR Section 807.92.

The assigned 510(k) Number: K163352

    1. Date of Preparation
      06/21/2017
  • Sponsor 2.

Kunshan Hi-Fortune Health Products Co.,Ltd.

No. 301,Qinhe Road, Zhangpu Town, Kunshan City, Jiangsu Province, China 215300 Establishment Registration Number: Not yet registered or the Number Contact Person: HongFa Zhi Position: General Manager Tel: +86-512-55195100 Fax: +86-512-55199300 Email: lance@hi-fortune.net

    1. Submission Correspondent
      Mr. Ray Wang

Beijing Believe Technology Service Co., Ltd. 5-1206, Build 332, DaFangJu, No.25 BanBiDian Rd., LiYuan Town, TongZhou District, Beijing, 101121, China Tel: +86-21-50313932 Fax: +86-21-68093116 Email: ray.wang@believe-med.com

4

    1. Identification of Proposed Device
      Trade Name: Wheelchair Common Name: Mechanical Wheelchair Model(s): HM303

Regulatory Information: Classification Name: Wheelchair, Mechanical Classification: I; Product Code: IOR; Regulation Number: 21 CFR 890.3850; Review Panel: Physical Medicine;

Intended Use Statement:

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

  • Device Description 5.
    The proposed device, Wheelchair model HM303, is traditional manually operated, user propelled, manual, mechanical wheelchairs. The device can be foldable easily for transport.

The main frame is made of magnesium alloy frame, which has a seat base with four-wheeled with a back cover. Upon the outside of this framework, and to the rear, are assembled two axle plates, wheels are connected to the stainless steel axle receivers via stainless steel axles. On the front end of the frame are assembled two caster housings. Caster forks are mounted to these housings via steel axles. On the front end of the frame, upon the caster, two footplates are assembled for foot holding. Two armrests are mounted on the frame for user's arm holding. Two grips mounted on the top end of the frame with a brake, and another brake is designed under the seat base. A folden set is on the frame, under the grips, for folding backrest.

5

6. Identification of Predicate Device

Predicate # 510(k) Number: K153328 Product Name: SUNCO Mechanical Wheelchair Manufacturer: Danyang Sunco Machinery Co., Ltd

Non-Clinical Test Conclusion 7.

Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:

Safety Testing

ISO 7176-1:2014 Wheelchairs - Part 1: Determination of static stability.

ISO 7176-3:2012 Wheelchairs – Part 3: Determination of effectiveness of brakes.

ISO 7176-5:2008 Wheelchairs - Part 5: Determination of dimensions, mass and manoeuvring space.

ISO 7176-7:1998 Wheelchairs - Part 7: Measurement of seating and wheel dimensions.

ISO 7176-8:2014 Wheelchairs - Part 8: Requirements and test methods for static, impact and fatigue strengths.

ISO 7176-11:2012 Wheelchairs - Part 11 Test Dummies

ISO 7176-13:1989 Wheelchairs - Part 13 Determination of Coefficient of Friction of Test Surfaces.

ISO 7176-15:1996 Wheelchairs – Part 15: Requirements for information disclosure, documentation and labeling.

ISO 7176-16:2012 Wheelchairs – Part 16: Resistance to ignition of postural support device. ISO 7176-22:2014 Wheelchairs - Part 22 Set-up Procedures

Biocompatibility Performance

Cytotoxicity Test

Test Method: MTT Method, MEM with 10%FBS extract

Test Standard: ISO 10993-5: 2009, Biological evaluation of medical devices - Part 5: Tests for In Vitro cytotoxicity.

Test Result: Did not show potential toxicity

Skin Sensitization Test

Test Method: Guinea Pig Maximization Test, 0.9% Sodium Chloride Injection Extract & Sesame oil Extract

Test Standard: ISO 10993-10: 2010, Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization.

Test Result: No significant evidence of causing skin sensitization.

Skin Irritation Test

Test Method: 0.9% Sodium Chloride Injection Extract & Sesame oil Extract

6

Test Standard: ISO 10993-10: 2010, Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization. Test Result: Negligible

    1. Clinical Test Conclusion
      No Clinical Test conducted.

7

9. Substantially Equivalent (SE) Comparison

Table 1 General Comparison

ITEMProposed DevicePredicate DeviceRemark
Product CodeIORIORSE
Regulation No.21 CFR 890.385021 CFR 890.3850SE
Class11SE
Intended UseThe device is intended for medical purposes to provide mobility to persons restricted to a sitting position.The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.SE
Design
CharacteristicManual Operation, Four-Wheels, Foldable, Cross-Brace, Pull/Push-to-Lock, Armrest, Backrest, FootpadManual Operation, Four-Wheels, Foldable, Cross-Brace, Pull-to-Lock, Armrest, Backrest, FootpadSE
Operation
EnvironmentFor Indoor/Outdoor useFor Indoor/Outdoor useSE

Table 2 Performance Comparison

ITEMProposed DevicePredicate DeviceRemark
Overall
DimensionsLength: 1137 mm (44.8")Length: 42"
Width: 680 mm (26.8")Width:25.2"Analysis
Height: 880 mm (34.6")Height:36"
Rear WheelSize: 559 mm (22")Size: 24"Analysis
Tire Type: RubberTire Type: PU Solid Material
Rim Diameter/Material: 510.7 mmRim Diameter/Material: 21"/Steel
(20.1")/Steel CompositeComposite
Wheel LockPull-to-Lock, Push-to-LockPull-to-LockSE
Ground Clearance64 mm (2.5")2.3"SE
Min. Turning
Diameter1915.2 mm (75.4")31"Analysis
ArmrestArm pad: PadedArm pad: PaddedSE
Height-Adjustable: NoHeight-Adjustable: No
Seat DimensionsDepth: 420 mm (16.5")Depth: 16"
Height: 470 mm (18.5")Height: 20"Analysis
Width: 410 mm (16.1")Width: 20"
CastersSize: 152 mm (6")Size: 7.9"Analysis
Tire Type: PUTire Type: PU Solid Material
Weight of
wheelchair11.07kg38.6lb/17.5kgAnalysis
Weight Capability100kg220lb/100kgSE

Difference Analysis:

The proposed device is substantially equivalent to the predicate device. Based on the nonclinical tests performed, the subject device is as safe, as effective, and performs as well as the legally marketed predicate device.

8

ITEMProposed DevicePredicate DeviceRemark
Performance TestComply with ISOComply with ISOSE
7176-1/-3/-5/-7/-8/-15/-167176-1/-3/-5/-7/-8/-15/-16
BiocompatibilityComply with ISO 10993-1Comply with ISO 10993-1SE
Label and
LabelingConforms to FDA Regulatory
RequirementsConforms to FDA Regulatory
RequirementsSE

Table 3Safety Comparison

10. Substantially Equivalent (SE) Conclusion

Based on the comparison and analysis above, the proposed device is determined to be Substantially Equivalent (SE) to the predicate device.